Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
08/2002
08/28/2002EP1233987A1 Immobilized single domain antigen-binding molecules
08/28/2002EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein
08/27/2002US6440667 Analysis of target molecules using an encoding system
08/27/2002US6440656 Methods for the inhibition of respiratory syncytial virus transmission
08/27/2002US6440461 Drug delivery; biocompatibility, biodegradable
08/27/2002US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides
08/22/2002WO2000033865A9 Methods of inhibiting ectopic calcification
08/22/2002US20020116733 Generating disease resistant plant sesds; obtain seeds, incubate with hypersensitive response protein, classify plants propagated from seeds
08/22/2002US20020115113 Conductive polymer matrix for use in the efficient isolation of preferential stem cells
08/22/2002US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris
08/22/2002DE10106295C1 Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist Protein with multiple antigen epitope sequences, which is immobilized
08/20/2002US6436903 Immunomodulating compounds comprising d-isomers of amino acids
08/20/2002US6436665 Providing in vitro translated protein attached to nucleic acid linker, binding encoding molecule to nucleic acid linker, thereby encoding protein
08/20/2002CA2063886C Polyethylene protein conjugates
08/15/2002WO2002062957A2 Ter sites and ter binding proteins
08/15/2002WO2002007707A3 Linkage of agents using microparticles
08/15/2002CA2438376A1 Method and apparatus for the production of antigens and uses thereof
08/15/2002CA2436986A1 Ter sites and ter binding proteins
08/14/2002EP1231282A2 Methods and compositions for identification of polymers
08/14/2002EP0701448B1 Amplification of the vitamin b 12 uptake system using polymers
08/14/2002EP0554389B2 Molecular clones of hiv-1 and uses thereof
08/13/2002US6432653 Separation of cells from lymphs or myeloid linage with bonding and contacting cells
08/08/2002WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
08/08/2002WO2001092883A3 Surface for the immobilisation of ligands
08/08/2002US20020106640 Peptide for use in the treatment and prevention of viral infection
08/07/2002EP1229122A2 Chimeric isoprenoid synthases and uses thereof
08/07/2002EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells
08/07/2002EP1229044A1 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of HIV infections
08/07/2002EP1228081A1 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events
08/07/2002CN1088721C Interferon conjugates
08/06/2002US6429300 Peptide acceptor ligation methods
08/01/2002WO2001034635A9 Methods and compositions for peptide synthesis
08/01/2002US20020103336 Cloning of chicken anemia dna
08/01/2002US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects
08/01/2002US20020102567 Method for comparing nucleic acid sequences
07/2002
07/30/2002US6426210 Storage of materials
07/30/2002US6426073 Genetic engineered polypeptides
07/30/2002CA2237357C Stable biotinylated biomolecule composition and methods
07/25/2002US20020098206 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
07/18/2002WO2002055561A1 Method for surface display of proteins on genetic carriers
07/18/2002WO2001040310A3 Immobilisation of proteins using a polypeptide segment
07/18/2002US20020094551 T2R taste receptors and genes ecncoding same
07/18/2002DE10065787C1 Verfahren zur Immobilisierung von Biomolekülen, funktionalisiertes Trägermaterial und seine Verwendung A process for the immobilization of biomolecules, functionalized support material and its use
07/17/2002EP0804219B1 Inhibin compositions and methods of use thereof
07/16/2002US6420171 Composite material for use in the isolation of aggregations of cells associate with preferential blood disorders
07/16/2002US6420169 Device for generating preferential nucleotide sequences; for use as tools drug design
07/16/2002CA2124580C Method for selecting recombinant microorganisms containing at their surface at least one molecule having enzymatic activity
07/11/2002US20020090671 Bone stimulating factor
07/10/2002EP1220868A1 Extracorporeal endotoxin removal method
07/09/2002US6416952 Photolithographic and other means for manufacturing arrays
07/09/2002US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion
07/04/2002WO2002051872A1 Method for immobilising biomolecules, functionalised carrier material, and the use thereof
07/04/2002WO2002051856A2 Method for immobilising probes, in particular for producing biochips
07/04/2002WO2002033116A3 Nucleic acid ligands to the prostate specific membrane antigen
07/04/2002US20020086977 Generating preferential solid support; mix hydrophilic and hydrophobic material, expose to water, remove hydrophobic material, solidify hydrophilic material
07/04/2002US20020086335 Nanoparticle for use as biosensors in the detection of nucleic acids, antigens, enzymes and enzyme substrates
07/04/2002US20020086034 Compositions and methods for treating viral infections
07/04/2002US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes
07/03/2002EP1219639A1 Materials for extracorporeal circulation, adsorbents for diabetic complication factors, containers for eliminating diabetic complication factors and method of eliminating diabetic complication factors
07/03/2002EP1218509A2 Fibroblast growth factor-like polypeptides
07/03/2002EP0938326A4 Synthetic phosphopeptides for treating bone diseases
07/02/2002US6413735 Method of screening for a modulator of angiogenesis
06/2002
06/27/2002US20020081737 Generating biocompatible bead; obtain bead, incubate with probes, immobilize probe to bead, recover bead
06/27/2002US20020081295 Virus-like particles for the induction of autoantibodies
06/26/2002EP1216060A2 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
06/26/2002EP0865486A4 Stable biotinylated biomolecule composition and methods
06/26/2002CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes
06/25/2002US6410713 Nucleotide sequences coding chaperone protein for use in the prevention and treatment of cancer, stress and heart defects
06/20/2002WO2002048193A2 Camelidae antibody arrays
06/20/2002WO2000056774A9 Methods of using bioelastomers
06/20/2002US20020077296 High-throughput screening method
06/20/2002US20020076835 Solid support for use in the purification of protein from sample
06/20/2002US20020076727 Microarrays of functional biomolecules and uses therefor
06/19/2002EP1214350A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm)
06/18/2002US6406897 Modified protein with improved stability coupled to glycan
06/18/2002US6406851 Method for coating a substrate quickly and uniformly with a small volume of fluid
06/18/2002US6406844 Screening an array for affinity with a receptor, two different molecules are polypeptides, amino acid sequences
06/13/2002US20020072074 Solid support for use as diagnostic tool in the analysis and separation of biopolymers
06/12/2002EP1213587A1 Particles having gelatin coatings of and processes for making same
06/12/2002EP1212452A1 Methods for encoding and sorting in vitro translated proteins
06/12/2002EP1212095A2 Process to make a sustained release formulation
06/12/2002EP1212075A1 Peptides capable of modulating the function of cd66 (ceacam) family members
06/11/2002US6403957 Nucleic acid reading and analysis system
06/11/2002US6403705 Molecular rod and uses
06/11/2002US6403374 Long wavelength engineered fluorescent proteins
06/11/2002US6403320 Support bound probes and methods of analysis using the same
06/06/2002WO2002044336A2 Method of making a protein polymer and uses of the polymer
06/06/2002WO2002044327A2 Method and apparatus for protein manipulation
06/06/2002WO2002028895A3 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
06/06/2002WO2001044302A3 Nanoscaled functional layer
06/06/2002WO2001012232A8 Process to make a sustained release formulation
06/06/2002CA2430559A1 Method of making a protein polymer and uses of the polymer
06/05/2002EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY
06/05/2002EP1210373A2 Congener independent detection of microcystin and nodularin congeners
06/05/2002EP1141375A4 Metallopeptide combinatorial libraries and applications
06/05/2002EP1071442A4 Methods and compositions for peptide synthesis
05/2002
05/30/2002WO2002042321A2 Mixed fibrils
05/30/2002US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
05/29/2002EP0665955B1 Particles having gelatin-aminodextran coatings of and processes for making same
05/29/2002CN1351505A Short-chain peptide dye conjagates used as contrast agents for optical diagnostics
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 107